Company Filing History:
Years Active: 2023-2025
Title: The Innovative Contributions of Florian Hebenstreit in Diatomaceous Earth Compositions
Introduction
Florian Hebenstreit is a notable inventor based in Munich, Germany, recognized for his groundbreaking work in the field of diatomaceous earth compositions. With two patents to his name, his innovations focus on enhancing the safety and efficacy of materials used in biopharmaceutical applications.
Latest Patents
Hebenstreit's latest patents showcase his dedication to improving diatomaceous earth compositions. The first patent details a "Diatomaceous earth composition with a low endotoxin content." This invention is an agglomerated mixture of calcined diatomaceous earth particles and water, specifically designed to have an endotoxin content equal to or less than 0.5 EU/mL. Additionally, it outlines a production method and highlights its use as a precoat agent for filtration in biopharmaceutical applications.
The second patent, "Diatomaceous earth composition containing salt water," presents an improved formula that incorporates at least one inorganic salt into the composition. This unique blend also features specific mass ratios that enhance its application in precoat filtration and dynamic body feed filtration, thereby advancing the field of biopharmaceutical processes.
Career Highlights
Florian Hebenstreit works at Sartorius Stedim Biotech GmbH, a prominent company dedicated to biopharmaceutical solutions. His contributions have been instrumental in developing innovative approaches for the application of diatomaceous earth in various industrial settings.
Collaborations
Throughout his career, Hebenstreit has collaborated with remarkable colleagues such as Karl Pflanz and Andreas Pickl. Their collective expertise fosters an environment of innovation, driving advancements in the technologies related to biopharmaceutical applications.
Conclusion
Florian Hebenstreit stands out as a pioneering inventor with impactful contributions in the realm of diatomaceous earth compositions. His patents not only enhance the safety standards within biopharmaceutical applications but also illustrate the potential for continued innovation in this vital field.